Arizona State Retirement System Eagle Pharmaceuticals, Inc. Transaction History

Arizona State Retirement System

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$34.37 - $60.07 $231,860 - $405,232	-6,746 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$54.32 - $64.31 $278,770 - $330,038	-5,132 Reduced 43.21%	6,746 $405,000
Q3 2019 Oct 31, 2019	SELL	$53.25 - $59.98 $218,591 - $246,217	-4,105 Reduced 25.68%	11,878 $672,000
Q2 2019 Jul 25, 2019	BUY	$46.61 - $58.45 $4,101 - $5,143	88 Added 0.55%	15,983 $890,000
Q1 2019 Apr 29, 2019	SELL	$38.66 - $51.82 $40,283 - $53,996	-1,042 Reduced 6.15%	15,895 $803,000
Q4 2018 Jan 28, 2019	BUY	$36.72 - $67.73 $28,458 - $52,490	775 Added 4.8%	16,937 $682,000
Q3 2018 Oct 29, 2018	BUY	$66.65 - $83.86 $271,332 - $341,394	4,071 Added 33.67%	16,162 $1.12 Million
Q2 2018 Aug 07, 2018	SELL	$51.25 - $76.62 $53,966 - $80,680	-1,053 Reduced 8.01%	12,091 $915,000
Q1 2018 May 14, 2018	SELL	$52.16 - $66.86 $46,944 - $60,174	-900 Reduced 6.41%	13,144 $693,000
Q4 2017 Feb 09, 2018	BUY	$49.6 - $60.87 $478,342 - $587,030	9,644 Added 219.18%	14,044 $750,000
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $205,128 - $265,584	4,400	4,400 $262,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.